Clinical trial
Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP Trial: COlchicine for Recurrent Pericarditis
NCT00128414 is registered in ClinicalTrials.gov with Azienda Sanitaria Locale 3, Torino as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP Trial: COlchicine for Recurrent Pericarditis
- Lead sponsor
- Azienda Sanitaria Locale 3, Torino
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- October 31, 2010
- Enrollment
- 120 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.